Research on hiv

There are scientific advancements that look promising for controlling and preventing the onset of Alzheimer's disease. Alzheimer's is such a complicated disease that most experts anticipate that a drug that will operate the disease will very likely consist of a drug cocktail. The treatment that is only intuit may consist of a regimen of drugs that is used to treat Aids.

The strengthen in the quest for a cure for Alzheimer's looks promising. any research scientists are being funded by The Alzheimer's Disease relationship as well as additional resources from incommunicable and philanthropic organizations. Scientists are gaining insights how the disease progresses in the brain. Many Experts believe that a new generation of treatments will evolve that will prevent, slow or perhaps reverse the damaging effects of Alzheimer's disease.

Research On Hiv

The newest discovery in the Alzheimer's research society is from the Uk. A team of research scientist led by Dr. Emma Kidd at Cardiff University's Welsh School of Pharmacy recently completed a study showing that it is possible to decrease production of a small protein called amyloid (A*), This protein is believed to be the main cause of the disease. The research was funded by the Alzheimer's Society, the Uk's important care and research charity for Alzheimer's disease and other types of dementia.

Researchers at the University of California, Los Angeles have discovered a new brain imaging aggregate that shows promise by giving researchers a way to detect Alzheimer's disease earlier. This imaging molecule can detect and map the plaques and tangles in the brains of population with Alzheimer's disease.

This discovery could finally lead to earlier analysis of the devastating disease. The aggregate is called Fddnp. Fddnp also holds promise as a research tool to evaluate new treatments for Alzheimer's. The study was funded in part by the National form on Aging (Nia), one of the National Institutes of health (Nih).

Alzhemed is being developed by Neurochem Inc. This enterprise is just months away from seeing out if the drug developed by their Quebec-based enterprise can actually slow the procedure of Alzheimer's disease. A clinical trial of the drug will wrap up in January, with results improbable in the spring.

The enterprise has been developing the drug for over 12 years. The focusing of the research and development team was one of the toughest challenges in medicine: retention Alzheimer's disease from slowly, relentlessly destroying the brain. The goal was something no drug has yet done.

There are also tests being conducted on a drug derived from a Chinese moss that has been used for more than 2,000 years in the Middle Kingdom to treat fevers. Dr. Aisen, a important researcher for Neurochem learned in 1999 that doctors in China had been using the drug, called Huperzine A, for 20 years to ease symptoms of Alzheimer's disease.

This drug is now made by Neuro-Hitech Inc. The drug improves memory in much the same way as Pfizer's Aricept and other Alzheimer's treatments. any way this natural derivative does not have the gastrointestinal side effects. Aisen was most intrigued by evidence that during research with mice, Huperzine-A protected brain cells from the ravages of plaque and tangles. No other drug has been able to perform that feat.

Over 12 million population worldwide suffer from Alzheimer's disease. The direct and indirect cost of caring for Alzheimer's victims in the United States alone is more than 0 billion a year. research to find a cure for this dreaded disease is on-going. Some of the most promising facts suggests that strategies for maintaining a salutary lifestyle may help reduce the risks of developing this disease.

Promising investigate For Alzheimer's Disease Cure

Thanks To : hiv antiretroviral drugs